SLSN Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -19.0%, SMA50 -33.9%, SMA200 -50.03%). The stock’s 14-day RSI is 29.61 (weak momentum), while the ATR of 0.19 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -90.37% below its high and over 19.03% above its low. Average 10-day trading volume of 38.06 thousand shares is below the 3-month average of 43.97 thousand, indicating normal recent market interest.

Solesence, Inc. Common Stock has 70.48 million shares outstanding. The public float is 18.20 million shares, elevated short interest at 5.40% of float. This equals 983.22 thousand shares. The short ratio is 13.37 days. Institutional investors hold 23.29% of the float. Insiders own 73.21%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Solesence, Inc. Common Stock (NASDAQ:SLSN) closed at $1.50 USD, losing -$0.09 (-5.96%) from the previous close of $1.59. The stock is currently mid-range between its 52-week high and low $1.34 and $16.56. With a market capitalization of about $105.81 million, Solesence, Inc. Common Stock is classified as a micro-cap and shows market-like volatility (beta ~1.07). Key stats such as the average daily volume over the past year has been around 39.29 thousand shares, in line with its 52-week average. Headquartered in Romeoville, IL, Solesence, Inc. Common Stock operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Kevin Cureton, the company employs approximately 98 people and listed since April 08, 2025. Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products.

Solesence, Inc. Common Stock trades at a P/E ratio of 20.57, slightly below the S&P 500 average, with a price-to-sales ratio of 1.68 and a price-to-book ratio of 5.92 trading at moderately above to book value. The P/FCF stands at -19.76, also below market averages.

Our AI price prediction model suggests that Solesence, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.67%, with price expected at $1.57 by January 14, 2026, within a range of $1.34 to $1.81 3-Month Outlook: Projected rise of 216.0%, reaching $4.74 by March 31, 2026, with a range of $4.03 to $5.33. 1-Year Outlook: Projected gain of 13.33%, with price at $1.70 by December 31, 2026, within a range of $1.16 to $1.88.

currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Solesence, Inc. Common Stock trading at a premium to the broader market with a P/E of 20.57. Our AI forecast model points to short-term strength (4.67% over two weeks), a medium-term rise (216.0% over three months), and a longer-term gain (13.33% over one year), with expected trading ranges indicating moderate volatility.

Solesence, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.98. This means the shares are trading below this model’s fair value.